Tuberculosis control in the Netherlands: current situation and five-year plan Every year on 24 March, the world marks ‘World TB Day’ to raise awareness for the global fight against tuberculosis (TB)– one of the world’s top infectious killers.
New possibilities for the responsible recycling of plastics RIVM proposes the consideration of a broader environmental perspective in the trade-off between incineration and recycling of plastics.
More tobacco products, number of additives stable In 2014, the number of tobacco products on the Dutch market increased to 4212. This is a 5 percent increase compared to 2013.
Discussions on internet forums as a valuable source to understand patients’ perspectives Patients' perspectives do not always correspond to those of healthcare professionals and policy-makers.
RIVM recommends more stringent EU standards BPA More stringent European standards for safe exposure of workers and consumers to bisphenol A (BPA) were proposed in 2014 and 2015.
INHERIT research project kicks off Maximising health equity and environmental sustainability: the INter-sectoral Health and Environment Research for InnovaTions (INHERIT) project has kicked off. RIVM experts joined 17
Historical research on reduction of childhood mortality due to vaccination To what extent has the National Vaccination Programme contributed to the prevention of disease and mortality since the beginning of the 20th century?
Need for adjustment authorisation for gene drive applications The National Institute for Public Health and the Environment (RIVM) advises to bring all gene drive applications under the authorisation requirement of the Dutch GMO legislation.
Chikungunya infections in the Caribbean region Since August 2014, there has been an increase in the number of Chikungunya patients in the Caribbean region. Travellers who visit the region can become infected there.
Dr. Els van Schie new director of Environment and Safety Dr. Els van Schie has been appointed RIVM Director of Environment and Safety as from 1 February 2015. She will succeed Dr. Marcel van Raaij and interim director Dr.